Elizabeth Anderson
Director/Board Member bei REVOLUTION MEDICINES, INC.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Elizabeth McKee Anderson currently works at BioMarin Pharmaceutical, Inc., as Independent Non-Executive Director from 2019, Insmed, Inc., as Independent Director from 2018, GSK Plc, as Independent Non-Executive Director from 2022, Bavarian Nordic GmbH, as Independent Director from 2017, Revolution Medicines, Inc., as Independent Director from 2015, Aro Biotherapeutics Co., as Independent Director from 2018, The Wistar Institute, as Trustee, Bryn Mawr Hospital Foundation, as Trustee, The Haverford School, as Trustee, and PureSight Advisory LLC, as Trustee & Principal.
Ms. Anderson also formerly worked at Centocor, Inc., as Director, Bavarian Nordic A, as Independent Director from 2017 to 2022, Huntsworth Ltd., as Independent Non-Executive Director from 2018 to 2019, Crucell Vaccines, Inc., as Director, Context Therapeutics LLC, as Director from 2018 to 2021, Johnson & Johnson, as VP & General Manager-Wyeth Lederle Vaccines from 1997 to 2009, Janssen Pharmaceuticals, Inc., as Vice President-Infectious Disease & Vaccines from 2003 to 2014, The American National Red Cross, as Vice President-Plasma Operations from 1989 to 1993, Rhone-Poulenc Rorer Pharmaceuticals, Inc., as Senior Vice President & General Manager from 1993 to 1997, Armour Pharmaceutical Co., as VP-Business Operations & GM-North America from 1993 to 1997, Centeon LLC, as Senior Vice President & GM-North America from 1993 to 1997, and Wyeth Lederle Vaccines SA, as Vice President & General Manager from 1997 to 2002.
Ms. Anderson received her undergraduate degree in 1979 from Rutgers State University of New Jersey, Masters Business Admin degree from Sellinger School of Business & Management, and Masters Business Admin degree from Sellinger School of Business & Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 23.05.2023 | 23 080 ( 0,01% ) | 2 Mio $ | 31.03.2024 | |
INSMED INCORPORATED
0,02% | 11.05.2023 | 27 672 ( 0,02% ) | 750 741 $ | 31.03.2024 |
| 26.09.2023 | 10 625 ( 0,01% ) | 342 444 $ | 31.03.2024 | |
GSK PLC
0,00% | 12.04.2024 | 928 ( 0,00% ) | 20 030 $ | 31.03.2024 |
Aktive Positionen von Elizabeth Anderson
| Unternehmen | Position | Beginn |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Director/Board Member | 01.03.2015 |
| INSMED INCORPORATED | Director/Board Member | 08.11.2018 |
| BIOMARIN PHARMACEUTICAL INC. | Director/Board Member | 10.07.2019 |
| GSK PLC | Director/Board Member | 01.09.2022 |
Aro Biotherapeutics Co.
 Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | Director/Board Member | 01.01.2018 |
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Director/Board Member | 01.01.2017 |
PureSight Advisory LLC
 PureSight Advisory LLC Packaged SoftwareTechnology Services PureSight Advisory LLC provides management software solutions. The private company is based in Newark. | Director/Board Member | - |
The Wistar Institute
 The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Director/Board Member | - |
| Bryn Mawr Hospital Foundation | Director/Board Member | - |
| ░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Ehemalige bekannte Positionen von Elizabeth Anderson
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Elizabeth Anderson
| Rutgers State University of New Jersey | Undergraduate Degree |
| Sellinger School of Business & Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| INSMED INCORPORATED | Health Technology |
| GSK PLC | Health Technology |
| BAVARIAN NORDIC A/S | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| Private Unternehmen | 16 |
|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
The American National Red Cross
 The American National Red Cross Medical/Nursing ServicesHealth Services The American National Red Cross provides blood collections and disaster relief services. The firm provides neutral humanitarian care to the victims of war, emergency assistance, disaster relief and education. It offers compensate services such as support and comfort for military members and their families, the collection, processing and distribution of blood products, educational programs that promote health and safety, and international relief and development programs. The company was founded by Clarissa Harlowe Barton in 1881 and is headquartered in Washington, DC. | Health Services |
Huntsworth Ltd.
 Huntsworth Ltd. Miscellaneous Commercial ServicesCommercial Services Huntsworth Ltd. is an international healthcare communications and public relations company. The Huntsworth Health division offers consulting and communications services to the healthcare and well-being industry. The Red division is a strategic communications consultancy offering public relations, digital, and content expertise. The company was founded on June 6, 1983 and is headquartered in London, the United Kingdom. | Commercial Services |
Crucell Vaccines, Inc.
 Crucell Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Crucell Vaccines, Inc. develops, manufactures and sells vaccines. The firm provides vaccines for antibiotics, immunocompromised, fever, vomiting and diarrhea problems such as Mefloquine, Chloroquine, Immune Globulin, OPV and Yellow fever vaccine. The company was founded in 1990 and is headquartered in Miami, FL. | Health Technology |
The Wistar Institute
The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Health Technology |
| Bryn Mawr Hospital Foundation | |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
| Armour Pharmaceutical Co. | |
| Centeon LLC | |
| The Haverford School | |
Wyeth Lederle Vaccines SA
 Wyeth Lederle Vaccines SA Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Wyeth Lederle Vaccines SA develops and manufactures pharmaceutical products. The private company is based in Louvain-la-Neuve, Belgium. | Health Technology |
PureSight Advisory LLC
PureSight Advisory LLC Packaged SoftwareTechnology Services PureSight Advisory LLC provides management software solutions. The private company is based in Newark. | Technology Services |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | Health Technology |
Context Therapeutics LLC
 Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Health Technology |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Health Technology |
